Tag - OTLC

Developments

Oncotelic moving closer to commercial launch of AI-enabled robotics

Oncotelic Therapeutics (OTCQB: OTLC) has announced an update on the advancement of its proprietary AI platform and robotic integration toward commercialization, following the integration of approximately 28 million...

April 30, 2026

Developments

Oncotelic completes Phase 1 study of OT-101 and IL-2 in metastatic solid tumors

Oncotelic Therapeutics (OTCQB:OTLC) announced it has completed Phase 1 of its trial evaluating OT-101 in combination with IL-2 for advanced metastatic tumors. According to Oncotelic, this announcement coincides with a...

March 25, 2025

Tag - OTLC

Oncotelic moving closer to commercial launch of AI-enabled robotics

Oncotelic completes Phase 1 study of OT-101 and IL-2 in metastatic solid tumors

Subscribe